🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and atrial fibrillation risk — November 2025 Page 7

GLP-1 and atrial fibrillation risk — November 2025

NurseLeah_Nash Mon, Oct 20, 2025 at 7:42 AM 39 replies 2,030 viewsPage 7 of 8
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Nov 23, 2025 at 12:42 AM#31
SleepDoc_PDX said:
Lp(a) and cardiovascular risk: a nuance that matters.

Bookmarking. The distinction being drawn above is the one nobody else makes.

Last edited: Nov 23, 2025 at 1:42 AM
39 14TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 36 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Nov 25, 2025 at 1:15 PM#32

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I would rather be corrected than agreed with, if it comes to it.

38 13james_edin, FranDenver, Dr.BariatricHTX and 35 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Nov 28, 2025 at 1:47 AM#33
Dr.EndoEP said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Second this. Nothing to add that would improve it.

Last edited: Nov 28, 2025 at 4:47 AM
37 12tommy_boulder, hyun_seoul, jim_asheville and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Nov 30, 2025 at 2:17 PM#34
Dr.EndoEP said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Adding the part of the answer the thread has not reached. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

36 11steve_okc, dave_SLC, FDA_TrackerJim and 33 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Dec 3, 2025 at 2:46 AM#35

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: Dec 3, 2025 at 3:46 AM
35 10jason_sac26, chris_chi24, tampaLisa73 and 32 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register